Shenzhen YHLO Biotech (SH:688575) Zhi Tong Cai Jing·2026-01-06 10:15Core Viewpoint - The company, Yahui Long (688575.SH), has signed a strategic cooperation framework agreement with Shenzhen Brain-Machine Starlink Technology Co., Ltd. to jointly develop brain-machine interface-related products and enhance treatment technologies for central nervous system diseases [1] Group 1: Strategic Cooperation - The strategic cooperation aims to integrate brain-machine interface technology with clinical and market resources to advance product development and market expansion [1] - The partnership is expected to enhance the company's competitiveness in the field of central nervous system diseases and expand its strategic layout in brain-machine interface-related areas [1] Group 2: Company Profile of Brain-Machine Starlink - Brain-Machine Starlink focuses on both non-invasive and invasive technology paths, driven by artificial intelligence, and aims to establish a comprehensive development system from basic research to industrial application [1] - The company has developed various products, including EEG collection and analysis instruments, brain-machine interface sleep aids, sleep monitoring devices, and vagus nerve stimulation devices [1] Group 3: Market and Product Development - The collaboration will leverage both parties' strengths to accelerate the development of diagnostic products for Alzheimer's disease, autism, depression, and other neurological disorders [1] - The integration of hardware terminals, algorithm models, and cloud services is part of the strategic vision for advancing brain-machine interface applications [1]